ImageneBio, Inc. (IMA) stock

IMANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30

$3.45−0.27 (-7.26%)

Close on Nov 12, 2026Market cap $39.16MP/E –Yield –

ImageneBio EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

ImageneBio's EPS for the twelve months ending Sep 30, 2024 was -$3.60. For fiscal 2025 it was -$9.64. The highest annual figure on record is -$1.22 in fiscal 2021.

Annual eps

Period	Period end	Value	Change
FY2025	Dec 31, 2025	-$9.64	–
FY2024	Dec 31, 2024	-$22.10	–
FY2023	Dec 31, 2023	-$1.63	–
FY2022	Dec 31, 2022	-$1.90	–
FY2021	Dec 31, 2021	-$1.22	–
FY2020	Dec 31, 2020	-$16.00	–

Quarterly eps

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q3 FY2026	Sep 30, 2026	-$0.91	–
Q2 FY2026	Jun 30, 2026	-$0.63	–
Q1 FY2026	Mar 31, 2026	-$0.95	–
Q3 FY2025	Sep 30, 2025	-$2.91	–
Q2 FY2025	Jun 30, 2025	-$4.46	–
Q1 FY2025	Mar 31, 2025	-$3.80	–
Q3 FY2024	Sep 30, 2024	-$2.58	–
Q2 FY2024	Jun 30, 2024	-$0.28	–
Q1 FY2024	Mar 31, 2024	-$0.33	–
Q4 FY2023	Dec 31, 2023	-$0.41	–
Q3 FY2023	Sep 30, 2023	-$0.40	–
Q2 FY2023	Jun 30, 2023	-$0.44	–
Q1 FY2023	Mar 31, 2023	-$0.39	–
Q4 FY2022	Dec 31, 2022	-$0.39	–
Q3 FY2022	Sep 30, 2022	-$0.48	–
Q2 FY2022	Jun 30, 2022	-$0.57	–
Q1 FY2022	Mar 31, 2022	-$0.47	–
Q3 FY2021	Sep 30, 2021	-$0.40	–
Q2 FY2021	Jun 30, 2021	-$0.35	–
Q1 FY2021	Mar 31, 2021	-$2.52	–
Q4 FY2020	Dec 31, 2020	-$8.43	–
Q3 FY2020	Sep 30, 2020	-$2.34	–
Q2 FY2020	Jun 30, 2020	-$1.89	–
Q1 FY2020	Mar 31, 2020	-$2.62	–